AwesomeCapital
Search This Blog
Friday, July 19, 2019
bluebird bio (BLUE) Named Best Ides for 2nd-Half at Gabelli
Gabelli analyst Jing He reiterated a Buy rating on bluebird bio (NASDAQ: BLUE) and named the stock its Best Idea.
https://www.streetinsider.com/Analyst+Comments/bluebird+bio+%28BLUE%29+Named+Best+Ides+for+2nd-Half+at+Gabelli/15719052.html
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.